Benutzerbeiträge
- 06:00, 27. Jan. 2018 (Unterschied | Versionen) . . (+468 Bytes) . . K Did not differ significantly from PHF alone treated samples. Hence, the
- 22:15, 26. Jan. 2018 (Unterschied | Versionen) . . (-214 Bytes) . . K Ncubated with PHF or PHF in combination with a 4E6, b (aktuell)
- 13:44, 25. Jan. 2018 (Unterschied | Versionen) . . (+13 Bytes) . . K Did not differ significantly from PHF alone treated samples. Hence, the
- 13:40, 25. Jan. 2018 (Unterschied | Versionen) . . (-395 Bytes) . . K Ve to untreated manage samples by day 7 (Fig. 5d). As was (aktuell)
- 03:35, 24. Jan. 2018 (Unterschied | Versionen) . . (+1.334 Bytes) . . N Ve to untreated control samples by day 7 (Fig. 5d). As was (Die Seite wurde neu angelegt: „As with the higher PHF dose, [https://dx.doi.org/10.1002/wcs.1183 title= wcs.1183] the two way ANOVA benefits showed a significant impact of treatment and time…“) (aktuell)
- 13:22, 22. Jan. 2018 (Unterschied | Versionen) . . (-23 Bytes) . . K Osure, whereas 6B2 has no effect Total TauFig. six Low dose PHF (aktuell)